Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.12.23 | Incyte and Syndax Pharmaceuticals: Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease | 675 | Business Wire | Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg dose achieving a complete or partial response within the first six months of treatment
Data are featured... ► Artikel lesen | |
10.12.23 | Innate Pharma SA: Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023 | 670 | Business Wire | Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will... ► Artikel lesen | |
10.12.23 | Belgian, Port Houston and Partners Sign Memorandum of Understanding on Energy Transition Cooperation | 469 | Business Wire | Today, H.E. Alexander De Croo, Prime Minister of Belgium, witnessed the signing of a Memorandum of Understanding on Energy Transition Cooperation between three Belgian and three Houston-based partners... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 708 |
NVIDIA | 461 |
DEUTSCHE BANK | 454 |
BAYER | 365 |
NEL | 319 |
TESLA | 307 |
RHEINMETALL | 267 |
TUI | 266 |
BYD | 257 |
SUPER MICRO COMPUTER | 245 |
BASF | 204 |
THYSSENKRUPP | 197 |
AIXTRON SE | 177 |
COMMERZBANK | 176 |
AMAZON | 175 |
MICROSOFT | 172 |
PLUG POWER | 171 |
RWE | 165 |
ALPHABET | 151 |
MERCEDES-BENZ | 151 |
META PLATFORMS | 151 |
INTEL | 144 |
VARTA | 144 |
DELIVERY HERO | 140 |
GALERIA KARSTADT KAUFHOF GMBH | 139 |